GSK plc today announced positive headline results from five studies of the Phase 3 ASCEND programme, for patients with anaemia due to chronic kidney disease (... Jul 17
Halozyme’s drug delivery technology provides the opportunity to administer large volume subcutaneous injections that may enable dosing intervals of every three months and up ... Jun 22
With this collaboration GSK is uniquely positioned with access to antibodies that synergistically target all three known CD226 checkpoints - TIGIT, CD96 and PVRIG.... Jun 14
GSK gets FDA nod for Jemperli indicated for endometrial cancer... Apr 26
GSK plc announced updated data from GARNET cohort F evaluating dostarlimab in mismatch repair-deficient non-endometrial advanced solid cancers being presented today at the ... Jan 18
... Jan 13
Vir Biotechnology, Inc. and GlaxoSmithKline plc today announced an agreement with the U.K.-based AGILE initiative to evaluate VIR-7832 in patients with mild ... Jan 12
The application includes data for a new, 50 mg tablet that can be dispersed in water and which was developed to facilitate use in children, ... Jan 08
This authorization represents the first time people living with HIV in Europe may be able to receive a long-acting injectable treatment that removes the ... Dec 21
ACTIV-3 is an NIH-led public-private partnership designed to accelerate the development of the most promising treatments and vaccine candidates for COVID-19.... Dec 18
BENLYSTA is the first medicine approved to treat systemic lupus and adults with active lupus nephritis, an important treatment advance for patients with this incurable ... Dec 18
Currently no vaccine is available for respiratory syncytial virus... Nov 23
GSK and MMV today presented positive data from the TEACH study of tafenoquine, an 8-aminoquinoline, for the prevention of relapse of Plasmodium vivax malaria ... Nov 20
Dolutegravir is the first integrase inhibitor available as a dispersible tablet for children... Nov 13
... Nov 12
Both candidate vaccines contain a recombinant subunit pre-fusion RSV antigen which is believed to trigger the required immune response... Oct 21
ViiV Healthcare, today announced the positive findings of a pooled analysis of COVID-19-related impacts across the investigational long-acting cabotegravir and rilpivirine clinical ... Oct 21
ViiV Healthcare announced CHMP issed positive opinion recommending Vocabria in combination with Rekambys and Edurant for the treatment of HIV-1 ... Oct 16
Vir Biotechnology, Inc. and GlaxoSmithKline today announced the global expansion to Phase 3 of the COMET-ICE study for the early treatment of COVID-19 ... Oct 06
Data presented may shift the treatment paradigm to 2-drug regimens (2DRs) for people living with HIV ... Oct 01
Third US indication for Nucala demonstrates GSK’s commitment to finding new ways to help patients with eosinophil-driven diseases... Sep 25
Sanofi and GSK finalised and signed today an advanced purchase agreement with the European Commission (EC) for supplying their vaccine... Sep 20
-Advertisements-
-23-300x250.png)
.jpeg)
Thursday, October 29, 2026
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
